2024-09-23 - Analysis Report
## Johnson & Johnson (JNJ) Stock Analysis

**Company Overview:** Johnson & Johnson is a multinational pharmaceutical, medical devices, and consumer packaged goods company.

**Performance Analysis:**

* **Cumulative Return:** JNJ has a cumulative return of 37.17%, lagging behind the S&P 500 (VOO) which has a cumulative return of 132.53%. This places JNJ at the 8.67th percentile of its historical performance relative to the S&P 500.
* **Recent Price Movement:** JNJ's current price is $164.16. The stock is trading below its 5-day ($165.82) and 20-day ($165.38) moving averages, suggesting potential downward pressure. However, it's above its 60-day moving average ($158.62), indicating a longer-term upward trend.
* **Technical Indicators:** 
    * **RSI:** JNJ's RSI of 44.48 indicates the stock is in a neutral territory, neither overbought nor oversold.
    * **PPO:** The PPO of -0.28 suggests a slight bearish signal, as the stock price is below its 20-day moving average.
    * **Delta_Previous_Relative_Divergence:**  The negative value of -3.1 suggests a short-term bearish trend.
    * **Expected Return:** The expected return of 13.39% is a potential maximum 5-year return based on current investment amounts.
* **Recent Earnings and Outlook:**
    | Date | EPS | Revenue |
    |---|---|---|
    | 2024-07-25 | 1.95 | 22.45 B$ | 
    | 2024-05-01 | 1.35 | 21.38 B$ | 
    | 2024-02-16 | 1.68 | 21.39 B$ |
    | 2023-10-27 | 10.32 | 21.35 B$ |
    | 2024-02-16 | 10.32 | 21.35 B$ |

The latest earnings report for Q2 2024 showed an EPS of $1.95, exceeding analysts' expectations. Revenue of $22.45 billion also beat estimates. The company's performance demonstrates a strong growth trajectory.

**Overall Analysis:**

JNJ is a stable and mature company with a consistent dividend history. Despite its recent underperformance compared to the S&P 500, the stock is showing some positive signs with its latest earnings report. The recent price movement, technical indicators, and positive earnings suggest that JNJ may be poised for a potential rebound. However, investors should continue to monitor the stock's performance and consider its overall market position before making any investment decisions.
